抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體
Anti-Actin Alpha 2, Smooth Muscle (ACTa2) Monoclonal Antibody
ACT-A2; ACTSA; ACTVS; Asma; GIG46; Cell growth-inhibiting gene 46 protein
- 編號FAB342Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 效價G5
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應(yīng)用FCM
- 下載英文說明書 中文說明書
- 規(guī)格25test50test100test200test500test
- 價格¥ 720¥ 1200¥ 1920¥ 2400¥ 4200
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human ACTa2 Monoclonal Antibody (Catalog FAB342Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
Human Jurkat cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human ACTa2 Monoclonal Antibody (Catalog FAB342Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB342Hu01 | 平滑肌肌動蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB342Hu02 | 平滑肌肌動蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPB342Hu21 | 平滑肌肌動蛋白α2(ACTa2)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAB342Hu01 | 平滑肌肌動蛋白α2(ACTa2)多克隆抗體 | WB; IHC |
| CAB342Hu01 | 抗平滑肌肌動蛋白α2(ACTa2)多克隆抗體 | WB; IHC |
| MAB342Hu22 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | WB |
| MAB342Hu21 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| CAB342Hu22 | 抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC/IF |
| MAB342Hu29 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu23 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu24 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu25 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu27 | 平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| FAB342Hu04 | 抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu02 | 抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu06 | 抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu08 | 抗平滑肌肌動蛋白α2(ACTa2)單克隆抗體 | FCM |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Cell Mol Immunol? | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica[Pubmed:27157496] |
| NAUNYN-SCHMIEDEBERGS?ARCHIVES OF?PHARMACOLOGY | Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats[Pubmed: 32936352] |
| Brazilian Journal of Pharmaceutical Sciences | Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm[] |
| Structural Changes and Detection of Liver Fibrosis¨CRelated Protein Levels in Coculture of Alveolar Echinococcosis-Protoscoleces and Human Hepatic Stellate cells[] | |
| Parasit Vectors | Structural changes and expression of hepatic fibrosis-related proteins in coculture of Echinococcus multilocularis protoscoleces and human hepatic stellate?…[34857049] |
| Clinical and Translational Medicine | NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine network[34459125] |